Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2015 Jul;151(7):703-4.
doi: 10.1001/jamadermatol.2014.4299.

Efficacy of Rapamycin in Tuberous Sclerosis-Associated Hypopigmented Macules: Back to the Future

Jack L Arbiser  1
Affiliations
Editorial

Efficacy of Rapamycin in Tuberous Sclerosis-Associated Hypopigmented Macules: Back to the Future

Jack L Arbiser. JAMA Dermatol. 2015 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: None reported.

Comment on

References

    1. Wataya-Kaneda M, Tanaka M, Yang L, et al. Clinical and histologic analysis of the efficacy of topical rapamycin therapy against hypomelanotic macules in tuberous sclerosis complex. JAMA Dermatol. doi: 10.1001/jamadermatol.2014.4298. published online February 18, 2015. - DOI - PubMed
    1. Bissler JJ, McCormack FX, Young LR, et al. Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. N Engl J Med. 2008;358(2):140–151. - PMC - PubMed
    1. Haemel AK, O’Brian AL, Teng JM. Topical rapamycin: a novel approach to facial angiofibromas in tuberous sclerosis. Arch Dermatol. 2010;146(7):715–718. - PubMed
    1. Zhang Y, Gao X, Saucedo LJ, Ru B, Edgar BA, Pan D. Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins. Nat Cell Biol. 2003;5 (6):578–581. - PubMed
    1. Fitzpatrick TB, Szabó G, Hori Y, Simone AA, Reed WB, Greenberg MH. White leaf-shaped macules. Earliest visible sign of tuberous sclerosis. Arch Dermatol. 1968;98(1):1–6. - PubMed